COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Copyright © 2020 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Modeling of nitrate leaching kinetics during spinach leaf midribs blanching
- Comparative study of total phenolic content and antioxidant proprieties of Quercus fruit: flour and oil
- Association of socioeconomic status, dietary behavior and obesity among Moroccan adults of the region of Rabat: A case-control study
- Acceptance of salt reduction in bakery bread among Moroccan consumers
You may also start an advanced similarity search for this article.
NAJFNR is licensed under 